Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-PREGABALIN | 25MG | CAPSULE | Resolved | 2018-01-09 | 2018-02-03 | 35498 |
| MINT-PREGABALIN | 50MG | CAPSULE | Resolved | 2018-01-09 | 2018-03-17 | 35501 |
| MINT-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2018-01-04 | 2018-02-23 | 34914 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-04-27 | 2020-10-10 | 113281 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-08-19 | 2020-11-11 | 122507 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-11 | 2021-06-22 | 131327 |
| MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2018-04-12 | 2018-05-16 | 45533 |
| MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2020-04-27 | 2020-11-11 | 113285 |
| MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35467 |
| MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108295 |
| MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35470 |
| MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108298 |
| MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35473 |
| MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-09 | 2021-01-16 | 108301 |
| MINT-QUETIAPINE | 25MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46030 |
| MINT-QUETIAPINE | 100MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46033 |
| MINT-QUETIAPINE | 200MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46038 |
| MINT-QUETIAPINE | 300MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46041 |
| MINT-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-04-12 | 2018-05-08 | 45536 |
| MINT-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-07-24 | 2024-01-09 | 199939 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |